Showcasing our AI-powered digital cytotoxicity and cell viability assay, we will explore how Nanolive’s high-content live cell imaging can be used to increase confidence in lead candidate selection.
We will explore the following drug discovery applications of Nanolive’s LIVE Cell Death Assay – all completely label-free:
Cell Death
- Drug screening in a 96-well plate
- Differentiating between necrotic and apoptotic cell death
- Detecting therapy resistance
Cell Health, Stress and Recovery
- Detecting cell stress before death
- Investigating therapy resistance using the Health Cell Index and Refractive Index imaging
- Monitoring cell recovery from the apoptotic pathway (anastasis)
The webinar will last around 20 to 25 minutes on the following dates and times:
31st of January at 10 am CET
31st of January at 5:30 pm CET
1st of February at 8 am CET
Hope Amos
Scientific Communication Specialist
Read our latest news
12 new scientific publications featuring Nanolive live cell data solutions
We have 11 new publications featuring Nanolive imaging to round-up the end of 2022, and one to welcome 2023! Find links to all twelve papers on topics from mitochondria, to neutrophils, leukemia, red blood cells, and bacteria below.We really saw an increase in groups...
A new diagnostic role for Nanolive’s refractive index imaging?
The refractive index of cellular structures is an intrinsic property that is used by Nanolive’s imaging and digital assays to analyse cells and organelles label-free. The authors of a newly published paper in Cells have innovatively applied this technology to monitor...
The Live T Cell Assay wins 5th place on The Scientist’s Top 10 Innovations of 2022
We are thrilled to announce that Nanolive's Live T Cell Assay has been ranked 5th in The Scientist's Top 10 Innovations of 2022! This groundbreaking tool captures detailed, multiplexed, and texturally rich images of the entire T cell response process without the use...
